Recilisib sodium
Catalog No: 17022712
CAS Number: 334969-03-8
Purity: 98%
Recilisib, also known as ON 01210.Na, is a radioprotectant, which modifys cell cycle distribution patterns in cancer cells subjected to radiation therapy, and it has been identified as a potential candidate for radiation protection studies. It appears that Recilisib radioprotective mechanisms involve prevention of p53-dependent and independent radiation-induced apoptosis.
For research use only. We do not sell to patients.
Chemical Information
| Name | Recilisib sodium |
|---|---|
| Iupac Chemical Name | Recilisib sodium |
| Synonyms | Recilisib; ON 01210.Na; ON-01210; ON01210; ON01210 |
| Molecular Formula | C16H12ClNaO4S |
| Molecular Weight | 358.7678 |
| Smile | c1cc(ccc1CS(=O)(=O)/C=C/c2ccc(cc2)C(=O)O)Cl |
| InChiKey | KBEKQQJUNVQLDZ-MDZDMXLPSA-N |
| InChi | InChI=1S/C16H13ClO4S/c17-15-7-3-13(4-8-15)11-22(20,21)10-9-12-1-5-14(6-2-12)16(18)19/h1-10H,11H2,(H,18,19)/b10-9+ |
| CAS Number | 334969-03-8 |
| MDL | MFCD07366276 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | off-white solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
